Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04565977 · ClinicalTrials.gov registry record
Evaluating Off-label Use of Direct Oral Anticoagulants (DOACs) in Hypercoagulable States
A clinical trial, sponsored by Methodist Health System.
- Completed
- Registry status
- 42
- Enrollment target
NCT04565977: Completed study, sponsored by Methodist Health System.
NCT04565977 is a clinical trial that has completed, run by Methodist Health System. The registered enrollment target is 42 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04565977 has completed, sponsored by Methodist Health System.
- COMPLETED
- Registry status
- 42 participants
- Enrollment target
Study Summary
Retrospective, cohort study chart review in patients with hypercoagulable states.
Primary Outcome
Rates of thrombotic events during the study period
Interventions
- OTHER Observational
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2020-07-01 |
| Est. Completion | 2021-06-10 |
What the finished NCT04565977 record still lists
NCT04565977 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 42 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Observational is the first listed.
NCT04565977 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04565977 about?
NCT04565977 is a clinical study titled "Evaluating Off-label Use of Direct Oral Anticoagulants (DOACs) in Hypercoagulable States". Retrospective, cohort study chart review in patients with hypercoagulable states.
What is the current status of trial NCT04565977?
This trial is currently completed. The enrollment target is 42 participants. The study started on 2020-07-01. Estimated completion is 2021-06-10.
What interventions are being tested in trial NCT04565977?
The interventions under investigation include: Observational (OTHER).
Who is sponsoring clinical trial NCT04565977?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02852213 · 42 participants · Phase 1
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
- NCT03136146 · 42 participants · Phase 2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- NCT03178149 · 42 participants · Phase 1
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- NCT03663530 · 42 participants · NA
Circadian Misalignment and Energy Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI